The rise of drug-resistant infections/antimicrobial resistance is the biggest threat to public health of our time and poses a life-or-death challenge to our health systems. It requires an urgent policy response at European, national and global levels. But is the EU itself resisting the call to take new measures which are up to the challenge of protecting public health?
Sessions
Attendees
Speakers
Relive the event
Download the available presentations
Dr Angelique Berg
Director General Health, Ministry of Health, The Netherlands
Dutch antibiotic resistance policy
Prof Johan Struwe
Antibiotics and Infection Control Analyst, Public Health Agency of Sweden
Swedish experiences in AMR containment and multisectoral stakeholders mobilization
Michele Cecchini
Policy Analyst, Health Division, OECD
Tajda Miharlja Gala
Vice-President, European Association of Hospital Pharmacists
The socio-economic challenges in combatting AMR from the hospital pharmacist practice perspective
Jurate Svarcaite
Secretary General, Pharmaceutical Group in the European Union
Contribution by community pharmacies to rational use of antibiotics
Michelle Childs
Head of Policy Advocacy, Drugs for Neglected Diseases Initiative (DNDi)
New models for R&D: The Global Antibiotic R&D Partnership
Prof Donald Broom
Emeritus Professor Animal Welfare, University of Cambridge
Antibiotic resistance, animal welfare and system sustainability
Peter Oostenbach
Associate Director Global Public Policy, MSD Animal Health
AMR and animal agriculture: Perspective from a global animal health company
Dr Mette Vaarst
Senior Researcher, Department of Anila Science, Aarhus University and International Centre for Research in Organic Food Systems
Conference highlights
- Intersectoral approach to a multifaceted global health threat
- Investing in public health: AMR as a case study
- The role of prevention
- Research and innovation
- AMR and animal agriculture
- Towards a One Health approach: Developing a global vision and taking policy action
- Networking opportunities
Conference Takeaways
- Insight into the socio-economic and structural factors behind the AMR crisis
- Identify cooperation opportunities to remove the barriers reluctance and resistance to tackling the AMR threat
- Updates on all fields impacted by AMR
- New perspectives by world-renowned contributors on your area of work.
From Twitter:
Follow the interactions online with the hashtag #EPHA2016!
#AMR is survival of the fittest. NOT only for doctors to solve, not just a medical issue – @CMO_England #EPHA2016 pic.twitter.com/20Ch3myMrR
— EPHA (@EPHA_EU) September 8, 2016
#AMR doubles mortality AND costs. Measures and prevention can and will improve both. @CMO_England #EPHA2016
— EPHA (@EPHA_EU) September 8, 2016
#AMR has a large cost for health care systems and the whole economy says M Cecchini #EPHA2016 @OECD_Social
— EPHA (@EPHA_EU) September 8, 2016
Current EU #AMR action plan 2011-2016 is not commensurate with scale of the problem says Xavier Prats Monne. #EPHA2016
— Nina @EPHA (@ninawren) September 8, 2016
EU can support global agenda on #AMR through development and trade says Xavier Prats-Monné #EPHA2016
— EPHA (@EPHA_EU) September 8, 2016